Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03983395 |
Title | Study of GBR 1302 (CD3 Bispecific Ab) in HER2-positive Metastatic Breast Cancer |
Recruitment | Terminated |
Gender | female |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Glenmark Pharmaceuticals S.A. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |